Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.
about
Immunotherapy for advanced renal cell cancerTargeted therapy for advanced renal cell carcinomaImmunotherapy for advanced renal cell cancerContemporary Treatment of Metastatic Renal Cell CarcinomaBone Metastasis from Renal Cell CarcinomaProteomics and peptidomics: moving toward precision medicine in urological malignanciesAxitinib in the treatment of renal cell carcinoma: patient selection and perspectivesSequence of treatment in locally advanced and metastatic renal cell carcinomaCytoreductive surgery in the era of targeted molecular therapyPancreatic Metastases from Tumors in the Urogenital TractTargeting PD-1/PD-L1 in the treatment of metastatic renal cell carcinomaPotential Role of MicroRNA-210 as Biomarker in Human Cancers Detection: A Meta-AnalysisEffects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumorsMultidisciplinary management of clear-cell renal cell carcinoma in Africa and the Middle East: current practice and recommendations for improvementProfile of tivozanib and its potential for the treatment of advanced renal cell carcinomaEffects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinomaMedical treatment of renal cancer: new horizonsIntegrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United StatesThe 'nivolution' in renal cell carcinoma: behind the scenes of clinical trials.Development and characterization of a novel mAb against bilitranslocase - a new biomarker of renal carcinoma.Determination of prognostic factors in Japanese patients with advanced gastric cancer using the data from a randomized controlled trial, Japan clinical oncology group 9912.Immunotherapy for advanced renal cell cancer.Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials.Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasisMetastatic renal cell cancer treatments: an indirect comparison meta-analysis.Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study.Sensitivity analysis to investigate the impact of a missing covariate on survival analyses using cancer registry data.A five-factor biomarker profile obtained week 4-12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2.Analysis of adverse events of sunitinib in patients treated for advanced renal cell carcinoma.(Pre-)clinical pharmacology and activity of pazopanib, a novel multikinase angiogenesis inhibitor.The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphomaStaging of renal cell carcinoma: Current concepts.Tetravalent antibody-scTRAIL fusion proteins with improved properties.Cytoreductive nephrectomy in the modern era: Predictors of use, morbidity, and survival.Active angiogenesis in metastatic renal cell carcinoma predicts clinical benefit to sunitinib-based therapy.Pazopanib-induced asymptomatic radiological acute pancreatitis: A case reportHyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma.Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial.Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model.
P2860
Q24187300-E048986A-A040-4D9C-A475-7FB78FFBC6C5Q24242946-B737A795-6BA9-403A-846E-9486349FB015Q24246777-1B44B124-FEAA-46A2-9081-FED5A1C07FF6Q26740594-41634ED3-F2DE-4C58-A241-65657ABDE8C6Q26747493-ADCD215A-0387-4A48-AA2C-13C51E6F8F93Q26749401-31A680F8-6224-43F4-BFE6-BAB1DF0E2B32Q26751341-12E4EC50-E67D-4925-8288-48381AB2D60AQ26773653-3C0920A5-3A19-427A-8114-7E5C4A3AAF1EQ26774134-5745A959-BABC-402A-86AF-584878574804Q26775539-C60D337B-99DE-4A84-B5CB-7686FBCD6A68Q26775769-025A76F4-FC7D-425A-A440-B068F89A9462Q26786404-82846500-B501-4808-9A2A-B77BCA8D1473Q26799046-B8AC2EDC-BBEE-4ACD-8A47-82C637301339Q26801279-31250597-0C58-4BC0-98B6-B05DD3AD928EQ26827319-28DF4A86-1646-4ED1-9CDF-4B760090543AQ27852038-292DA123-466F-414A-95FF-8251F7B13A64Q28067482-D4B848FE-79BB-4CCE-A1AD-FF497CF55523Q28073174-E59DAC38-A707-49AA-9405-5897C006017CQ28487676-B6BCAE05-A673-4097-B5DA-BA4DE2EF96ECQ30250343-49718F5E-87E3-4117-8903-599BB1AABB62Q30432428-E16665BD-672A-4937-97A8-1CC2D8545A34Q30785622-A05288F3-7E3B-4054-9E0C-AE1248CF2521Q30887373-ECC45B5E-CDDD-446F-99EA-DEE69E898E1BQ31162395-D6DA40FD-36D7-4FF0-8492-D90EE01CED34Q33294127-4AC8BE75-B75C-4598-9CD3-4CA8EE2EED95Q33403399-B6D46F83-6C6C-4DB2-8E51-934DD31B0E68Q33406542-E3D9F783-D56B-4C83-8F35-10A46B26E919Q33411401-B99EA97A-D00B-4FB1-A33A-04FDC6980BE1Q33426559-94B73230-8EE8-4B73-AF93-34E481F25AE1Q33432282-BBCAB9B9-A6B2-4255-8B13-59A1121571E0Q33590458-4CC3A004-7533-4C5C-BF0F-3B659E978362Q33597192-D90378BA-9DA0-41D8-A646-1EE36FDAC6F8Q33599726-5FA8E544-AB94-499A-9281-BB4DFB48D8C5Q33619046-414DF29E-BF46-4B60-B1D0-92673610075EQ33665043-67DBE326-E590-46F8-A761-4DBE80521DF1Q33682981-95A80201-B318-406F-81ED-8051B4F7A335Q33686273-DEE2A237-6099-46D0-87F2-7AC300D2EC7EQ33708148-164D9408-FB52-4D1E-92A7-6B71F4A82296Q33716744-1120354D-A9E3-4FBF-A908-0C7BFF1A7D0BQ33721389-65FC02B5-A4FC-49C3-B031-DEA44F89113D
P2860
Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Survival and prognostic strati ...... advanced renal cell carcinoma.
@ast
Survival and prognostic strati ...... advanced renal cell carcinoma.
@en
type
label
Survival and prognostic strati ...... advanced renal cell carcinoma.
@ast
Survival and prognostic strati ...... advanced renal cell carcinoma.
@en
prefLabel
Survival and prognostic strati ...... advanced renal cell carcinoma.
@ast
Survival and prognostic strati ...... advanced renal cell carcinoma.
@en
P2093
P1476
Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma
@en
P2093
P304
P356
10.1200/JCO.1999.17.8.2530
P407
P577
1999-08-01T00:00:00Z